Estratégias para reduzir a inflamação periférica e o risco de Alzheimer

Com base em pesquisas genómicas que ligam as origens do Alzheimer à inflamação em tecidos periféricos como o intestino, pulmões ou pele, medidas práticas de estilo de vida podem ajudar a conter a inflamação crónica. Estas incluem vacinação, higiene oral, dieta, exercício, controlo de peso e gestão do stress, oferecendo benefícios para a saúde geral em meio a uma ciência em evolução.

Estudos genómicos recentes, incluindo a análise de Cesar Cunha de mais de 85.000 casos de Alzheimer e milhões de células individuais (medRxiv DOI: 10.64898/2026.02.09.26344392), sugerem que o risco de Alzheimer pode começar décadas antes com atividade imunitária elevada em órgãos periféricos em vez do cérebro. Embora a causalidade não esteja provada e a investigação continue, reduzir a inflamação persistente — distinta das respostas benéficas de curto prazo a lesões — é prudente para uma saúde mais ampla, podendo mitigar riscos de cancro, doenças cardíacas, AVCs, artrite, depressão e Alzheimer. Key strategies include: Vaccinations: Shots against shingles (Shingrix reduced dementia by 17% over six years vs. Zostavax), flu, and tuberculosis lower inflammation and dementia odds, aligning with findings on midlife infections. Oral hygiene: Preventing gum disease blocks bacteria from entering the bloodstream, curbing systemic inflammation linked to Alzheimer's and heart issues. Mediterranean diet: Emphasizing fruits, vegetables, beans, nuts, whole grains, fish, and olive oil while limiting red/processed meats supports a healthy gut microbiome and dampens inflammation, promoting longevity. Exercise: Any regular activity, including yoga (per 2024 meta-analysis), reduces inflammation markers, as confirmed by 2021 reviews. Weight management: Combating obesity-related inflammation; GLP-1 drugs like semaglutide (Ozempic) for type 2 diabetes correlate with lower dementia risk, though benefits for non-diabetics and established Alzheimer's are unclear. Stress reduction: Chronic stress fuels inflammation; fostering well-being helps counteract this. Estes hábitos melhoram a saúde física e mental de forma holística, complementando a mudança para estratégias de prevenção de corpo inteiro na investigação do Alzheimer.

Artigos relacionados

Lab scene illustrating breakthrough Alzheimer's drug candidates: Zostavax vaccine, sildenafil (Viagra), riluzole with brain model and expert panel.
Imagem gerada por IA

Experts flag shingles vaccine, sildenafil and riluzole as leading Alzheimer’s repurposing candidates

Reportado por IA Imagem gerada por IA Verificado

A University of Exeter-led study funded by Alzheimer’s Society has identified three already-approved medicines—the shingles vaccine Zostavax, sildenafil (Viagra) and riluzole—as top “priority” candidates to be tested in clinical trials for Alzheimer’s disease, after a structured review of 80 existing drugs by an international expert panel.

A new genomic analysis suggests that Alzheimer's disease may begin with inflammation in organs like the skin, lungs, or gut, potentially decades before brain symptoms appear. Researchers analyzed genetic data from hundreds of thousands of people and found risk genes more active outside the brain. This perspective could reshape prevention and treatment strategies.

Reportado por IA

A team of researchers led by Professor Yan-Jiang Wang has published a review arguing that Alzheimer's disease requires integrated treatments targeting multiple factors, not single causes. New drugs like lecanemab and donanemab offer modest benefits by slowing decline, but fall short of reversal. The paper, in Science China Life Sciences, emphasizes genetics, aging, and systemic health alongside amyloid-beta and tau proteins.

Older adults carrying high-risk APOE4 gene variants experienced slower cognitive decline and lower dementia risk with higher meat consumption, according to a Karolinska Institutet study of over 2,100 participants tracked for up to 15 years. Findings suggest diet's effects on brain health vary by genetics, challenging one-size-fits-all advice.

Reportado por IA Verificado

Researchers at Case Western Reserve University report that some gut bacteria can make unusually inflammatory forms of glycogen and that this microbial glycogen can trigger immune activity linked to brain inflammation in models of disease tied to the C9orf72 mutation. In patient stool samples, the team found these glycogen forms more often in ALS and C9orf72-related frontotemporal dementia than in healthy controls, and enzymatically breaking down glycogen in the gut improved outcomes in mice.

quarta-feira, 15 de abril de 2026, 04:46h

Lifelong cognitive enrichment tied to lower Alzheimer’s risk and later symptom onset, study finds

terça-feira, 24 de março de 2026, 10:36h

Severe infections raise dementia risk in large Finnish study

sexta-feira, 13 de março de 2026, 18:17h

Shingles virus may accelerate aging and dementia risk

quinta-feira, 26 de fevereiro de 2026, 22:51h

Shingles vaccine associated with slower biological aging

terça-feira, 24 de fevereiro de 2026, 06:42h

Study links brain blood flow changes to Alzheimer's risk

sábado, 21 de fevereiro de 2026, 00:18h

Air pollution linked to higher Alzheimer's risk in older Americans

sexta-feira, 20 de fevereiro de 2026, 18:53h

Scientists explain how exercise shields brain from Alzheimer's

domingo, 15 de fevereiro de 2026, 20:19h

AI tool maps causal gene-control networks in Alzheimer’s brain cells

terça-feira, 27 de janeiro de 2026, 17:07h

Study finds obesity and high blood pressure directly cause dementia

sexta-feira, 23 de janeiro de 2026, 02:51h

Study suggests APOE gene drives most Alzheimer's cases

Este site usa cookies

Usamos cookies para análise para melhorar nosso site. Leia nossa política de privacidade para mais informações.
Recusar